PBIGF vs AMGN: Which Stock is Better?
Side-by-side comparison of Paradigm Biopharmaceuticals Limited and Amgen Inc in 2026
PBIGF
Paradigm Biopharmaceuticals Limited
$0.18
AMGN
Amgen Inc
$349.39
Key Metrics Comparison
| Metric | PBIGF | AMGN | Winner |
|---|---|---|---|
| Market Cap | $81.32M | $187.71B | AMGN |
| P/E Ratio | N/A | 24.45 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | 0.5% | 0.1% | PBIGF |
| Gross Margin | 24.5% | 70.8% | AMGN |
Analyze PBIGF
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBIGF or AMGN a better investment?
Comparing PBIGF and AMGN: Paradigm Biopharmaceuticals Limited has a market cap of $81.32M while Amgen Inc has $187.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBIGF and AMGN?
PBIGF (Paradigm Biopharmaceuticals Limited) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBIGF or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PBIGF or AMGN?
PBIGF has higher revenue growth at 0.5% vs 0.1% for AMGN.
Which company is more profitable: PBIGF or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 24.5% for PBIGF.
Which is the larger company: PBIGF or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $187.71B compared to $81.32M for PBIGF.
Should I buy PBIGF or AMGN in 2026?
Both PBIGF and AMGN have investment merit. PBIGF trades at $0.18 while AMGN trades at $349.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBIGF and AMGN stock?
Key differences: Market Cap ($81.32M vs $187.71B), P/E Ratio (N/A vs 24.5x), Revenue Growth (0.5% vs 0.1%), Gross Margin (24.5% vs 70.8%).